Codiak BioSciences, Inc. Common Stock
CDAK
CDAK was delisted on the 4th of April, 2023.
27 hedge funds and large institutions have $1.44M invested in Codiak BioSciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
33% less funds holding
Funds holding: 40 → 27 (-13)
75% less capital invested
Capital invested by funds: $5.76M → $1.44M (-$4.32M)
93% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$17K |
| 2 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$5.72K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.5K |
| 4 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$1.11K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$199 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.31M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$265K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$135K |
| 4 |
Renaissance Technologies
New York
|
-$120K |
| 5 |
AG
Artal Group
Luxembourg
|
-$80K |
CDAK Hedge Fund Activity: Q1 2023 in Review
27 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Codiak BioSciences, Inc. Common Stock (CDAK) for Q1 2023, worth a combined $1.44M — down 75% from $5.76M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CDAK and 1 opened new positions — a net loss of 13 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $17K. The largest seller was Fidelity Investments, cutting an estimated $2.31M.
- 27 institutional investors held Codiak BioSciences, Inc. Common Stock (CDAK) as of Q1 2023, down from 40 in Q4 2022.
- Funds reported $1.44M of Codiak BioSciences, Inc. Common Stock stock for Q1 2023, down 75% quarter-over-quarter.
- 1 fund opened new Codiak BioSciences, Inc. Common Stock positions in Q1 2023 and 14 closed out, a net change of -13 holders.
- The largest Codiak BioSciences, Inc. Common Stock buyer in Q1 2023 was HRT Financial, an estimated $17K added.
- The largest Codiak BioSciences, Inc. Common Stock seller in Q1 2023 was Fidelity Investments, an estimated $2.31M sold.
Based on aggregated 13F filings for Q1 2023.